{"name":"Agen Biomedical","slug":"agen-biomedical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPb2h2eHpmeF9aVEtwVUVWSXJ5cWlqVjRMOGwtd1Brc2xKQUlEZUk5UnlaSGVGVUZ6cnFyZDE3c01nS3VTbWJaNnBZc20xZE9vVDFsOUxXeC1wVmh4eDhyaUo2N0tPOS1nb3YydHVFWVVzeDdIRGJnVEpyeU9uM2dTTmNBeGNBbld5TGlkUkhrQUpLcUdhd0RkVFZXeEZVOFc4bGc?oc=5","date":"2024-02-27","type":"pipeline","source":"Seeking Alpha","summary":"Agenus: A Would-Be Rockstar Held Back By Middling Financials (NASDAQ:AGEN) - Seeking Alpha","headline":"Agenus: A Would-Be Rockstar Held Back By Middling Financials (NASDAQ:AGEN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPc1VTRWVHQm5mdE9uRFMyR3Zrd3B5RU9lM240UGhvZThkX01ROTc4YnhMOTltN0xZY0ZBejBra3VEZlU4cXJYNWhBQXQtNUR3Rkx2LU1ZclM4SXVLVjVhWkhfb29VYkxCbTQyRTJPanlycUdEYzhmZEl0S3BGVm5vVG9iSUh5Nk95akxyclViNTlhNkE?oc=5","date":"2024-01-18","type":"pipeline","source":"Seeking Alpha","summary":"Agenus Stock: 2024 May Finally Be The Year For A Major Turnaround (NASDAQ:AGEN) - Seeking Alpha","headline":"Agenus Stock: 2024 May Finally Be The Year For A Major Turnaround (NASDAQ:AGEN)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}